References of "Bourhaba, Maryam"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailA pauci-symptomatic case of documented Hantavirus (Puumala) infection in a patient under anti-TNF treatment.
Moutschen, Pierre; Bourhaba, Maryam ULg; FRIPPIAT, Frédéric ULg et al

in Journal of Clinical Virology (2011), 50(3), 247-8

We describe the case of an 18-yr-old male under anti-TNF treatment for Crohn's disease for more than 8 months. He developed fever and biological inflammatory syndrome without absolutely no accompanying ... [more ▼]

We describe the case of an 18-yr-old male under anti-TNF treatment for Crohn's disease for more than 8 months. He developed fever and biological inflammatory syndrome without absolutely no accompanying sign or symptom or paraclinical abnormality despite extensive work-up performed in the context of his immunocompromised state. Symptoms disappeared after 10 days and a diagnosis of Puumala infection was made retrospectively on a serological basis. The case illustrates that anti-TNF treatment does not worsen the course of Puumala infection and could even be associated with a milder clinical picture. [less ▲]

Detailed reference viewed: 39 (6 ULg)
Full Text
Peer Reviewed
See detailLe cancer du sein de la femme âgée
MARTIN, Marie; COLLIGNON, Joëlle ULg; RORIVE, Andrée ULg et al

in Revue Médicale de Liège (2011), 66(5-6), 400-408

Detailed reference viewed: 35 (1 ULg)
Full Text
Peer Reviewed
See detailL’image du mois. Localisation rénale d’un lymphome
Dispas, Hélène; Delperdange, Mélanie; Meunier, Paul ULg et al

in Revue Médicale de Liège (2010), 65(7-8), 427-429

Detailed reference viewed: 20 (4 ULg)
Full Text
Peer Reviewed
See detailL'Hantavirose fait encore parler d'elle
Bourhaba, Maryam ULg; GIOT, Jean-Baptiste ULg; Tshialala, D. M. et al

in Revue Médicale de Liège (2006), 61(5-6, May-Jun), 322-8

We propose a review of history, aetiology, physiopathology, clinical features, treatment and prevention of nephropathia epidemica (NE) which represents the only form of Hantavirus infection in Belgium.

Detailed reference viewed: 47 (3 ULg)
Full Text
Peer Reviewed
See detailDoit-on encore recommander le vaccin BCG?
Collette, Georges ULg; Bourhaba, Maryam ULg; Moutschen, Michel ULg

in Revue Médicale de Liège (2006), 61(5-6, May-Jun), 430-2

The BCG vaccine has demonstrated its efficacy to protect young children from severe extrapulmonary forms of tuberculosis. Nevertheless, the immunity induced by the vaccine disappears in adults and cannot ... [more ▼]

The BCG vaccine has demonstrated its efficacy to protect young children from severe extrapulmonary forms of tuberculosis. Nevertheless, the immunity induced by the vaccine disappears in adults and cannot be boosted by readministration of BCG. Adverse effects of BCG are rare, but potentially dangerous (i.e. disseminated vaccinal infections) and they justify the fact that BCG should not be administered anymore in Western European countries where the incidence of pediatric tuberculous meningitis is very low. The vaccine is still recommanded for children living in countries with high tuberculosis prevalence and for resident children leaving Belgium for these countries. [less ▲]

Detailed reference viewed: 38 (1 ULg)